<aside> 🧨 We couldn’t be more excited to welcome you to Kernel! This page will provide an introduction to the Kernel platform including an overview of the core components and the current state of the software.
</aside>
Section Overview:
<aside> 💡 Kernel by Valence is a secure, cloud-native platform that enables drug discovery scientists to integrate the full power of AI-based generative chemistry into their drug discovery programs.
</aside>
The Kernel platform complements and supports the design-make-test-analyse (DMTA) cycles that are core to drug discovery teams. It enables the tracking of multiple projects and DMTA cycles simultaneously while supporting parallel work-streams and discovery strategies.
Kernel is focused on enabling collaboration; through Kernel’s visualization, review and comment features, drug discovery scientists can quickly analyze the most promising compounds from Valence’s AI-based generative chemistry engine. Teams can also design new compounds for scoring and evaluation while further exploring the chemical space of interest with the help of our generative and predictive models. This is all done while providing access to key information on molecular structure, predicted activity across properties of interest, and more, all built directly and accessible through the Kernel platform.
Kernel is quickly evolving with new exciting features being deployed every week to adapt to your drug discovery needs. If you have any questions or feedback, please contact us at: [email protected] - we would love to hear from you!
As a review tool in the drug discovery process, Kernel provides the ability to: